This review examines its erectile dysfunction (ED) services, looking closely at what Hims offers its users, comparing its prices, researching how long it takes for Hims ED medications to work ...

Hims & Hers releases Super Bowl ad criticizing pharmaceutical industry and weight loss market, promoting their compounded GLP ...

Hims & Hers may leverage FDA compounding exemptions to further extend its compounded GLP-1 offerings. Learn why HIMS stock is ...

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late. Shares of the San Francisco, CA-based health and wellness platform have surged 69.2 ...

Learn more about whether Chemed Corporation or Hims & Hers Health, Inc. is a better investment based on AAII's A+ Investor ...

Established in 2017, Hims & Hers Health (NYSE: HIMS) is a relatively young company addressing age-old healthcare challenges by offering prescription medications, over-the-counter products ...

The millennial-targeted telehealth company Hims & Hers (HIMS) is spending big bucks on its first ever Super Bowl commercial to hawk its affordable weight-loss treatments. With Super Bowl ads ...

1 Day HIMS 9.78% DJIA -0.75% S&P 500 -0.50% Retail/Wholesale 0.77% ...